ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Divella et al. presented that obesity, insulin resistance, and altered adipocytokines (low adiponectin, high leptin, and TNF-α) not just increase the risk of colorectal cancer (CRC) but also lead to CRC hepatic metastasis due to NAFLD mediated liver inflammation [18].